Wellington Management Group
EWTX icon

Wellington Management Group’s Edgewise Therapeutics EWTX Stock Holding History

Wellington Management Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
25,659
-1,750
-6% -$60.3K ﹤0.01% 1744
2026
Q1 		$863K Sell
27,409
-83,978
-75% -$2.42M ﹤0.01% 1703
2025
Q4 		$2.76M Sell
111,387
-3,144
-3% -$63.1K ﹤0.01% 1521
2025
Q3 		$1.86M Buy
114,531
+1,961
+2% +$27.8K ﹤0.01% 1650
2025
Q2 		$1.48M Sell
112,570
-733
-0.6% -$10.6K ﹤0.01% 1646
2025
Q1 		$2.49M Sell
113,303
-89,590
-44% -$2.35M ﹤0.01% 1512
2024
Q4 		$5.42M Sell
202,893
-2,428
-1% -$77.3K ﹤0.01% 1332
2024
Q3 		$5.48M Sell
205,321
-288,526
-58% -$5.74M ﹤0.01% 1309
2024
Q2 		$8.89M Buy
493,847
+20,944
+4% +$365K ﹤0.01% 1183
2024
Q1 		$8.63M Buy
472,903
+131,997
+39% +$2.1M ﹤0.01% 1180
2023
Q4 		$3.73M Hold
340,906
– – ﹤0.01% 1370
2023
Q3 		$1.95M Hold
340,906
– – ﹤0.01% 1475
2023
Q2 		$2.64M Hold
340,906
– – ﹤0.01% 1425
2023
Q1 		$2.27M Hold
340,906
– – ﹤0.01% 1484
2022
Q4 		$3.05M Hold
340,906
– – ﹤0.01% 1400
2022
Q3 		$3.35M Hold
340,906
– – ﹤0.01% 1390
2022
Q2 		$2.71M Hold
340,906
– – ﹤0.01% 1483
2022
Q1 		$3.31M Sell
340,906
-340,906
-50% -$4.39M ﹤0.01% 1493
2021
Q4 		$10.4M Hold
681,812
– – ﹤0.01% 1246
2021
Q3 		$11.3M Sell
681,812
-59,776
-8% -$1.08M ﹤0.01% 1241
2021
Q2 		$15.5M Sell
741,588
-824
-0.1% -$22.5K ﹤0.01% 1159
2021
Q1 		$23.1M Buy
+742,412
New +$24.1M ﹤0.01% 1034

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's EWTX Position: Q2 2026 in Review

Wellington Management Group reduced its Edgewise Therapeutics (EWTX) stake by 6.4% in Q2 2026, selling an estimated $60.3K and leaving 25,659 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Wellington Management Group first reported a position in EWTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $23.1M in Q1 2021. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Wellington Management Group held 25,659 shares of Edgewise Therapeutics worth $1.04M as of Q2 2026.
  • Wellington Management Group sold 1,750 Edgewise Therapeutics shares in Q2 2026, an estimated $60.3K.
  • Edgewise Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1744 holding.
  • Wellington Management Group first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Wellington Management Group's Edgewise Therapeutics position peaked at $23.1M in Q1 2021.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.